UOC
SRRA

UBS O'Connor’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

UBS O'Connor’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-33,735
Closed -$1.85M – 1083
2022
Q2 		$1.85M Buy
+33,735
New +$1.77M 0.02% 669

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

UBS O'Connor's SRRA Position: Q3 2022 in Review

UBS O'Connor sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 33,735 shares — an estimated $1.85M sold.

UBS O'Connor first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $1.85M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • UBS O'Connor reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • UBS O'Connor sold 33,735 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $1.85M.
  • UBS O'Connor first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • UBS O'Connor's Sierra Oncology, Inc. Common Stock position peaked at $1.85M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.